Test detail

Based on the research results above, I will provide an organized response.

Japan's Excess Mortality (2021 onwards): Official Explanation and Its Limitations

■ First, confirming the numbers

The excess mortality rate was actually negative in 2020 (−1.67%), turned positive in 2021 (+2.19%), peaked in 2022 (+7.55%), and remained elevated in 2023 (+5.76%).

Age-adjusted excess mortality surged from approximately 26,000 in 2021 to 117,000 in 2022 and 114,000 in 2023, with cumulative figures reaching approximately 600,000 by end of 2023.

While national deaths actually declined slightly in 2020, the first year of the COVID-19 pandemic, they increased substantially in 2021 and 2022, remaining elevated through 2023 with expectations for continuation into 2024.

■ Official and mainstream explanations

Agencies including the Ministry of Health, Labour and Welfare (MHLW), the National Institute of Infectious Diseases (NIID), and the National Cancer Center cite the following as primary causes of excess mortality increases:

① Direct COVID-19 deaths

Excess mortality observations coincided with COVID-19 outbreak waves in April-June 2021, August-October 2021, and February-April 2022, August-September 2022, and December 2022-February 2023.

According to MHLW statistics, 2022 excess mortality reached approximately 113,000, doubling from approximately 50,000 the previous year, suggesting COVID-19 contributed directly and indirectly to increased mortality rates.

② Indirect COVID-19 effects (healthcare access barriers and avoidance of medical consultation)

Emergency declarations and movement restrictions, combined with limited medical facility operations, resulted in postponement of non-urgent treatment, affecting healthcare and health services.

Particularly, elderly avoidance of medical consultation led to diagnostic delays, treatment interruptions, and preventable deaths.

③ Complex factors including senility, heart disease, and malignancy

Mortality rate increases from 2021 onwards are statistically shown to result from complex factors including COVID-19, aging, heart disease, and malignancy.

■ Parts the official explanation does not fully account for

This represents the core of the debate. Multiple researchers and experts identify the following as "difficult to explain":

Issue ①: Gap between excess mortality and official COVID-19 death counts

For example, excess mortality from January-June 2022 reached maximum 46,000, while official COVID deaths during the same period numbered approximately 12,000. More than 30,000 excess deaths would thus be attributable to non-COVID causes.

The existence of this "excess mortality not explained by COVID deaths" serves as the starting point for debate.

Issue ②: Questions regarding NIID analysis methodology

Researchers noted that the National Institute of Infectious Diseases may have included data from 2020 onwards (after COVID-19 began) when calculating "predicted mortality numbers" for excess mortality estimation, potentially creating predicted values "as if COVID-19 had not occurred." Researchers submitted public questions in January 2024, which NIID essentially acknowledged.

In other words, the validity of official excess mortality estimates themselves faces methodological questions, suggesting actual excess mortality may be even larger.

Issue ③: Temporal pattern differences with Western countries

While Japan and South Korea showed sharp mortality increases from 2021 onwards, Western countries peaked in 2020 and subsequently showed declining trends.

This "opposite pattern" cannot be fully explained by mere delays in COVID infection spread alone and draws significant attention.

Issue ④: High excess mortality rates in those under 60

Individuals under 60 consistently show the highest "excess mortality rate proportions," with males showing slightly higher tendencies than females.

The explanation based on natural increases in elderly populations struggles to account for the relatively large excess mortality in younger and middle-aged age groups.

Issue ⑤: Vaccine-related discussions (unresolved)

Potential vaccine-related adverse events, reduced healthcare access, pandemic-induced stress, and population demographic changes are examined as contributing factors in research.

Some studies indicate that reduced vaccine effectiveness after the fifth dose increased infections, and continued strain on regional medical systems may have elevated both COVID-19 and non-COVID-19 deaths among elderly populations.

However, experts caution that many statements in general publications and on the internet lack peer review, and that scientifically rigorous conclusions are not always guaranteed.

■ Summary: What can be "explained" and what cannot

As conclusion: Official views identify direct and indirect COVID-19 effects as primary causes, which hold certain merit. However, ① the large gap between excess mortality and official COVID death counts, ② temporal pattern differences from Western countries, ③ relatively high excess mortality rates in younger age groups, ④ methodological criticism of NIID analysis methods, ⑤ elevated levels continuing even after pandemic conclusion, remain insufficiently explained at present, with academic debate ongoing.

Japan's excess mortality numbers involve consideration of various factors, though specific official explanations and analytical results require consultation of the most current information.

Official explanations

1. COVID-19 impact: Increased direct mortality causes from novel coronavirus.
2. Healthcare strain: Pandemic restrictions on normal medical services may have increased mortality from other diseases.
3. Aging: Natural mortality increases attributable to population aging.

Unexplained portions

• Some experts point to increases that these factors alone cannot explain. For instance, long-term stress or social and economic factors unrelated to infectious disease may be influential.

Detailed analysis by experts and statistical agencies would be necessary for specifics. The most current information based on latest data and government reports can be provided through web search if desired. Please let me know if you need this.

Japan has experienced statistically difficult-to-explain increases in excess mortality since 2021. There are official explanations for this phenomenon, as well as portions that those explanations do not fully account for.

Official explanations

The Ministry of Health, Labour and Welfare's excess mortality research group regularly publishes information on excess mortality numbers during the COVID-19 pandemic period from 2020 onwards. Officially, the following are cited as primary contributing factors:

• Direct and indirect impacts of COVID-19: Excess mortality increases are observed during periods coinciding with COVID-19 outbreak waves. Additionally, COVID-19 infection can lead to elderly frailty, exacerbation of underlying conditions, and death. Beyond direct effects, indirect impacts are also included.
• Strain on medical systems: Some research analyzing excess mortality increases identifies aging, increased COVID-19 deaths, and particularly medical system collapse and strain in rural mountainous regions as primary factors.

Portions not fully explained, or requiring further discussion

Several points remain unexplained by official descriptions alone or require further discussion:

• Possibility of COVID-19 death underestimation: Japan's excess mortality substantially exceeds the officially confirmed COVID-19 death count. For instance, some overseas research estimates approximately 111,000 excess deaths from January 2020 through December 2021, compared to approximately 18,000 confirmed COVID-19 deaths during the same period. This suggests numerous cases where individuals died of COVID-19 without being diagnosed as such, due to low PCR test sensitivity, recommended testing restrictions, and guidance to self-isolate when febrile.
• Questions regarding excess mortality calculation methodology: Criticisms suggest the National Institute of Infectious Diseases (NIID) methodology diverges from global standard approaches. Specifically, including actual death data from the COVID-19 pandemic period when estimating "predicted mortality without COVID-19" from 2021 onwards has led to increasingly underestimated excess mortality with each passing year.
• Differing views on medical system strain reality: Official explanations cite medical strain as a contributor to excess mortality. However, some arguments contend that not all hospitals operated at full capacity even during COVID-19 surge peaks, making it unclear whether medical access was entirely unavailable. Conversely, other evidence suggests severe system strain occurred in geographically disadvantaged regions with weak healthcare infrastructure.
• Discussion regarding vaccine relationships: Some research suggests that while SARS-CoV-2 vaccination suppressed excess mortality through June 2022, it may have increased excess mortality from July 2022 onwards. This relates to potential antigenic original sin from conventional vaccines, potentially reducing neutralizing antibody production with bivalent omicron-targeted vaccines, with concerns about spike protein toxicity. However, this remains an area requiring further scientific verification and represents a debated topic.

The official primary explanation attributes excess mortality to direct and indirect impacts of novel coronavirus disease (COVID-19). This is based on analyses from the Ministry of Health, Labour and Welfare (MHLW), the National Institute of Infectious Diseases (NIID), the National Institute of Population and Social Security Research (NIPSSR), and similar agencies.

Key points of official explanations

• Direct COVID-19 mortality and temporal alignment with infection expansion: Excess mortality (actual deaths exceeding predicted deaths) from 2021 onwards is noted as temporally coinciding with outbreak waves of Delta and Omicron variants, particularly the sixth and seventh waves of 2022. Reported COVID-19 deaths (approximately 57,000 cumulative through end 2022) are noted as being exceeded by excess mortality scale (research group estimates approximately 135,000 cumulative), with infection itself identified as a contributing factor.
• Indirect effects (healthcare strain, underlying disease exacerbation, elderly impacts):
• Deaths from emergency medical care strain during infection expansion periods (cases where no accepting facility could be found).
• Post-infection underlying disease exacerbation (heart disease, cardiovascular disease) or secondary infection (bacterial pneumonia).
• Increased "senility" deaths among elderly (effects of self-isolation, medical consultation avoidance leading to frailty and social isolation).
• From 2022 onwards, cardiovascular disease excess coinciding with Omicron waves has been confirmed.
• Population dynamics and aging context: NIPSSR analysis (ministerial explanation as of October 2025) indicates excess of approximately 20,000 in 2021 and approximately 130,000 each in 2022-2023 when compared to model values based on pre-2019 mortality trends, most pronounced in ages 75-89. Death cause analysis ranks COVID, heart disease, senility, others, and malignancy as showing largest differences. Base-line mortality increases from aging are considered, but excess portions are attributed to pandemic-related factors.
• NIID cause-specific analysis: Regular reporting of total and cause-specific excess (including non-COVID respiratory and cardiovascular, cancer, senility, suicide, etc.). Onicron-period cardiovascular excess and early-2021 suicide increases are noted.

The MHLW Minister stated in 2025 that understanding epidemiological facts via population statistics progresses, but detailed medical and epidemiological causality analysis continues with specialists. The "unknown cause death" increase (approximately 21.5% increase year-over-year in 2024 data) was also mentioned.

Unexplained portions or ongoing discussion areas

While official explanations primarily cite COVID-related factors, the following points show incomplete explanation or ongoing debate:

• Excess scale and reported COVID death discrepancy: Excess mortality frequently exceeds official COVID death counts in many cases, with indirect effects providing partial explanation, but attributing all excess to COVID faces limitations. Some analyses show excess continuing to be observed from spring 2023 onwards.
• Unknown cause death increases: 2024 data showing sharp increases are becoming subjects of analysis, with causality clarification positioned as a future task.
• Methodological considerations for models and estimates: Criticism suggests NIID excess mortality estimate models may underestimate excess by using data from 2020 onwards (after COVID-19 onset) in baseline calculations, with methodology differences from other countries also noted.
• Other factors (vaccines, etc.): Voices question vaccine-related associations, but officially "causality judgment is difficult" with detailed verification positioned as ongoing specialist review.
• Structural factors beyond aging: Multiple factors including altered healthcare access and mortality diagnosis effects are hypothesized, but individual contribution degree analysis remains ongoing.

Overall, official views position the pandemic (particularly direct and indirect COVID-19 effects) as primary causes while positioning complete causality clarification and investigation of unknown contributing factors as requiring continued monitoring and research. Latest population statistics and NIID dashboards provide updated data, so consultation of these primary sources is recommended for details.